The American Society of Breast Surgeons (ASBrS) has released new screening mammography guidelines based on a patient’s individual breast cancer risk profile. The American College of Radiology announced their support for the new recommendations.

The American Heart Association, alongside the American Cancer Society Cancer Action Network, American Lung Association, American Academy of Pediatrics and Tobacco-Free Kids, is throwing its support behind federal efforts to raise the tobacco sale age to 21 nationwide.

A pilot that aims to study the use of blockchain-enabled data technology to track and verify specialty prescription drugs has been approved by the FDA.

The American Society for Radiation Oncology (ASTRO) and the American Urological Association (AUA) have updated their clinical guidelines for adjuvant and salvage radiotherapy following prostatectomy.

Heart disease might be the leading cause of death in the United States, but, according to a recent report, it’s also one of the least searched-for diseases on the internet.

Ablacon, a Colorado-based company leveraging AI to develop an advanced mapping system to aid in the treatment of atrial fibrillation, has raised $21.5 million in a Series A funding round, the company announced.

The FDA has expanded Praluent’s (alirocumab) regulatory approval to reflect the reduced risk of heart attack, stroke and unstable angina evidenced in 2018’s ODYSSEY OUTCOMES trial—a move announced the same day drugmaker Sanofi released its first-quarter earnings, which were lower than expected.

CMS saw an influx of public commentary after it first published a draft of recommendations for revising the United States’ national coverage determination (NCD) for transcatheter aortic valve replacement (TAVR) more than a month ago. Now that the 30-day comment period is over, the agency has a decision to make.